Skip to content ↓

Topic

MIT Sloan School of Management

Download RSS feed: News Articles / In the Media / Audio

Displaying 1 - 15 of 492 news clips related to this topic.
Show:

Forbes

Writing for Forbes, Senior Lecturer Guadalupe Hayes-Mota '08, SM '16, MBA '16 emphasizes the importance of implementing ethical frameworks when developing AI systems designed for use in healthcare. “The future of AI in healthcare not only needs to be intelligent,” writes Hayes-Mota. “It needs to be trusted. And in healthcare, trust is the ultimate competitive edge.” 

Financial Times

Writing for the Financial Times, Principal Research Scientist Florian Berg explores “reasons to be hopeful about the resilience of efforts to tackle environmental issues at the corporate level.” Berg explains: “When looking at reporting on carbon emissions, ESG data and money invested in sustainable investment strategies, we can see big increases in recent years.” 

WBUR

Prof. Pierre Azoulay speaks with WBUR’s Martha Bebinger about a new study examining the potential impact of NIH budget cuts on the development of new medicines. Azoulay and his colleagues found that “more than half of drugs approved by the FDA since 2000 used NIH-funded research that would likely not have happened if the NIH had operated with a 40% smaller budget,” Bebinger explains. 

Fierce Biotech

Fierce Biotech reporter Darren Incorvaia writes that a new study by MIT researchers demonstrates how potential NIH budget cuts could endanger the development of new medications. The researchers found that if the NIH budget had been 40% smaller from 1980 to 2007, the level of NIH cuts currently being proposed, “the science underlying numerous drugs approved in the 21st century would not have been funded,” Incorvaia explains. The findings suggest that “massive cuts of the kind that are being contemplated right now could endanger the intellectual foundations of the drugs of tomorrow,” explains Professor Pierre Azoulay. 

Genetic Engineering & Biotechnology News

A new study co-authored by MIT researchers finds that more than half of the drugs approved by the FDA since 2000 are connected to NIH research that would be impacted by proposed 40 percent budget cuts, reports Genetic Engineering & Biotechnology News

Boston.com

According to the U.S. News & World Report rankings for 2025-2026, MIT has been named the No. 2 best university in the United States, reports Madison Lucchesi for Boston.com

Fortune

Edward Woodford SM '15 founded Zerohash, a crypto and stablecoin infrastructure company, aimed at helping “financial institutions and fintechs build out their own products for stablecoins, crypto trading, and tokenization,” reports Ben Weiss for Fortune. “Over eight years, Woodford has managed to ride multiple crypto booms and busts,” writes Weiss. “It’s not just that we’re a survivor,” says Woodford. “We’ve actually thrived in that market, and actually now, I think we can accelerate that even further.”

New York Times

MIT has been named the second best university in the United States, according to the U.S. News and World Report rankings for 2025-2026, reports Alan Blinder for The New York Times

The Boston Globe

U.S. News & World Report has named MIT the number two best university in the United States for 2025-2026, reports Emily Sweeney for The Boston Globe. The rankings “evaluated more than 1,700 colleges and universities in the United States, using up to 17 measures of academic quality and graduate success,” adds Sweeney. 

Newsweek

MIT has been named the number two college in the United States in U.S. News & World Report’s annual ranking, reports Alia Shoaib for Newsweek. “U.S. News & World Report ranks more than 1,700 colleges using a weighted formula that considers factors such as graduation and retention rates, faculty resources, academic reputation, financial resources and student selectivity,” explains Shoaib. 

Forbes

Prof. Dimitris Bertsimas, vice provost for MIT Open Learning, speaks with Forbes contributor Aviva Legatt about AI usage among university students. “Universities have a responsibility to ensure students, faculty, and staff gain a strong foundation in AI’s concepts, opportunities, and risks so they can help solve society’s biggest challenges,” says Bertsimas.

Bloomberg

Richard Locke PhD '89, the newly appointed dean of the Sloan School of Management, speaks with Bloomberg reporter Bill Donahue about his goals for his new role and his desire to help Sloan’s “brilliant, curious students” address urgent global problems. “For me, working at a place like MIT is a completely unexpected gift,” says Locke. “Every single day, I come to work with wonder and happiness. I’m in a world that I never imagined I would ever be in.” 

Boston Globe

Boston Globe reporter Jon Chesto spotlights the kickoff event for the new MIT-GE Vernova Energy and Climate Alliance, which will “fund research initiatives, fellowships, and other programs with an eye toward improving energy technologies and decarbonization.” GE Vernova CEO Scott Strazik emphasized that he has been impressed with the passion and talent for clean-tech among the students at MIT and other universities. “I started these discussions with the objective that we should inspire future leaders to come into our industry and ideally come to our company,” Strazik said. “They’ve probably inspired us more than we’ve inspired them.”

CNBC

MIT’s Sloan School of Management has been recognized as one of the top ten best MBA programs in the world, according to LinkedIn’s 2025 rankings, reports Kamaron McNahir for CNBC. 

GBH

Prof. Thomas Kochan speaks with GBH reporter Craig LeMoult about the recent Market Basket’s leadership dispute. “The reality is Market Basket is a community asset,” says Kochan. “People value it because it provides good service, good prices, good jobs. And the public is hungry for a company like that. And they demonstrated that in 2014 when the first episode occurred and everyone rallied around the employees who rallied their CEO.”